首页> 外文OA文献 >Fine specificity of cytotoxic T lymphocytes primed in vivo either with virus or synthetic lipopeptide vaccine or primed in vitro with peptide
【2h】

Fine specificity of cytotoxic T lymphocytes primed in vivo either with virus or synthetic lipopeptide vaccine or primed in vitro with peptide

机译:用病毒或合成脂肽疫苗在体内引发或在肽中体外引发的细胞毒性T淋巴细胞的优良特异性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Standard synthetic peptide preparations contain numerous peptidic byproducts in small amounts, which may be efficiently recognized by cytotoxic T lymphocytes (CTL). Recognition patterns of such peptide mixtures by CTL may serve as a kind of fingerprint for CTL fine specificity. Three types of H-2Db-restricted CTL were compared in this way. CTL primed in vivo either with A/PR/8/34 influenza virus or with a synthetic lipopeptide vaccine prepared from influenza nucleoprotein (NP) peptide 365-380 showed identical fine specificity. Both recognize virus-infected cells. In contrast, CTL primed in vitro with NP 365-380 had a different fine specificity and they did not recognize virus- infected cells. Most significantly, the two in vivo primed CTL types efficiently recognized the natural viral nonapeptide NP 366-374 presented by virus-infected H-2b cells, whereas the in vitro primed CTL failed to do so.
机译:标准的合成肽制剂含有少量的大量肽类副产物,这些副产物可以被细胞毒性T淋巴细胞(CTL)有效识别。 CTL对此类肽混合物的识别模式可作为CTL精细特异性的一种指纹。以此方式比较了三种类型的H-2Db限制性CTL。用A / PR / 8/34流感病毒或由流感核蛋白(NP)肽365-380制备的合成脂肽疫苗在体内引发的CTL表现出相同的优良特异性。两者都识别病毒感染的细胞。相反,体外用NP 365-380引发的CTL具有不同的精细特异性,并且它们不识别被病毒感染的细胞。最显着的是,两种体内引发的CTL类型均能有效识别病毒感染的H-2b细胞呈现的天然病毒九肽NP 366-374,而体外引发的CTL则不能。

著录项

  • 作者

  • 作者单位
  • 年度 1991
  • 总页数
  • 原文格式 PDF
  • 正文语种 {"code":"en","name":"English","id":9}
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号